Feasibility of Screening for Antibiotic Resistance - Part I

Abstract

During their duties, military personnel can be exposed to military relevant agents. In order to start a rapid and efficient therapy, especially in the case of micro-organisms that are resistant to (several) antibiotics, the identity of both the agent and the genes associated with the resistance against antibiotics must be known. A method that provides rapid and unequivocal information on the presence of specific genes is essential. Polymerase Chain Reaction (PCR) is such a method. The results obtained in this report suggest that it is possible to detect specific genes that are related to resistance against antibiotics such as tetracycline and ampicillin. It is also possible to detect mutations in essential genes of bacteria that are related to resistance against military relevant antibiotics such as ciprofloxacin. Detection of such genes with PCR or detection of mutations by means of PCR, followed by DNA sequencing can help to construct the outline of an efficient therapy. This will contribute to fulfilling one of the main objectives of the Ministry of Defense in the area of `Passive NBC Protection', i.e. `Protection of personnel against adverse health effects as a result of (non intentional) exposure to biological agents under operational circumstances'.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2005
Accession Number
ADA452804

Entities

People

  • A. M. De Vries
  • M. Polhuijs

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Amino Acids
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Bacteria
  • Bacterial Infections
  • Biological Factors
  • Biological Warfare
  • Biological Warfare Agents
  • Chain Reactions
  • Chemical Reactions
  • Classification
  • Detection
  • Dna Sequence Analysis
  • Gammaproteobacteria
  • Infection
  • Military Personnel
  • Polymerase Chain Reaction

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Microbial Pathology
  • Molecular and genetic basis of cancer.